UBX logo

Unity Biotechnology, Inc. (UBX)

Profile

Full Name

Unity Biotechnology, Inc.

Ticker

NASDAQ: UBX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 3, 2018

Indexes

Not included

Website

https://unitybiotechnology.com

Employees

16

Key Details

Price

$0.07

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.54(+42.96% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.07
    UBX price is $0.07

    30-Day Relative Volume

    0.21
    UBX 30-day relative volume is 0.21

    Price Performance

    Price Most recent change

    -
    UBX price change on Sep 9, 2025 is unknown

    Price YTD change

    -93.34%
    UBX price is down -93.34% since January 1st

    Price 1-year change

    -95.42%
    UBX price is down -95.42% year-on-year

    Price 3-year change

    -98.6%
    UBX price is down -98.6% over the past 3 years

    Price Range

    Price All-time high

    $245.60
    UBX price is currently -99.97% below its historical high of $245.60

    Price 3-year low

    $0.05
    UBX price is currently +33.47% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.12M
    UBX market capitalization is $1.12 million

    Market cap 3-year change

    -98.28%
    UBX market capitalization is down -98.28% over the past 3 years

    Market cap All-time high

    $971.98M
    UBX market capitalization is currently -99.88% below its historical high of $971.98 million

    Market cap sector rank

    3.86%
    UBX market capitalization is higher than 3.86% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.16%
    UBX shares outstanding is up +2.16% year-on-year

    Shares Outstanding 3-Year Change

    +22.75%
    UBX shares outstanding is up +22.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.94
    UBX beta is 0.94

    200-day SMA

    $0.99
    UBX price is currently -93.46% below its 200-day simple moving average

    50-day SMA

    $0.11
    UBX price is currently -43.28% below its 50-day simple moving average

    RSI

    38.46
    UBX 14-day relative strength index is 38.46

    Volume

    0.21
    UBX 30-day relative volume is 0.21

    ATR

    $0.02
    UBX average true range is $0.02

    10-day Historical Volatility

    183.20%
    UBX 10-day historical volatility is 183.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    UBX annual revenue value is unknown

    Revenue Analysts estimate

    -
    UBX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    UBX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    UBX annual revenue is unknown

    EPS

    EPS

    -$1.54
    UBX annual earnings per share is -$1.54

    EPS Analysts estimate

    -$1.13
    UBX annual earnings per share is currently +36.11% higher than the consensus analysts' forecast

    EPS 1-year change

    +42.96%
    UBX annual earnings per share is up +42.96% year-on-year

    EPS Sector rank

    42.07%
    UBX annual earnings per share is higher than 42.07% of companies in Healthcare sector

    Profit

    Gross profit

    -
    UBX annual gross profit value is unknown

    Gross margin

    -
    UBX annual gross profit margin value is unknown

    Operating profit

    -$28.47M
    UBX annual operating income is -$28.47 million

    Operating margin

    -
    UBX annual operating profit margin value is unknown

    Net income

    -$25.99M
    UBX annual net profit is -$25.99 million

    Net margin

    -
    UBX annual net profit margin value is unknown

    Expenses

    Total expenses

    $28.47M
    UBX annual total expenses is $28.47 million

    Operating expenses

    $28.47M
    UBX annual total operating expenses is $28.47 million

    Cost of goods sold

    -
    UBX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $15.46M
    UBX annual SGA is $15.46 million

    Depreciation and amortization

    $867.00K
    UBX annual depreciation & amortization is $867.00 thousand

    Interest expense

    $0.00
    UBX annual interest expense is $0.00

    Income tax

    -
    UBX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$25.99M
    UBX annual earnings before interest & taxes is -$25.99 million

    EBITDA

    -$25.12M
    UBX annual EBITDA is -$25.12 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $37.66M
    UBX annual total assets is $37.66 million

    Non current assets

    $13.39M
    UBX annual long term assets is $13.39 million

    Current assets

    $24.27M
    UBX annual total current assets is $24.27 million

    Cash and cash equivalents

    $7.58M
    UBX annual cash & cash equivalents is $7.58 million

    Accounts receivable

    -
    UBX annual accounts receivable value is unknown

    Inventory

    -
    UBX annual inventory value is unknown

    Liabilities

    Total liabilities

    $31.17M
    UBX annual total liabilities is $31.17 million

    Long term liabilities

    $21.91M
    UBX annual total long term liabilities is $21.91 million

    Current liabilities

    $9.26M
    UBX annual total current liabilities is $9.26 million

    Accounts payable

    $997.00K
    UBX annual accounts payable is $997.00 thousand

    Debt

    Total debt

    $23.54M
    UBX annual total debt is $23.54 million

    Total debt 1-year change

    -12.79%
    UBX annual total debt is down -12.79% year-on-year

    Long term debt

    $19.71M
    UBX annual long term debt is $19.71 million

    Short term debt

    $3.83M
    UBX annual short term debt is $3.83 million

    Equity & Capital

    Shareholders equity

    $6.49M
    UBX annual stockholders equity is $6.49 million

    Book value

    $6.49M
    UBX annual book value is $6.49 million

    Retained earnings

    -$510.34M
    UBX annual retained earnings is -$510.34 million

    Working capital

    $15.01M
    UBX annual working capital is $15.01 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$20.86M
    UBX annual cash flow from operations is -$20.86 million

    Cash from operations 1-year change

    +43.74%
    UBX annual cash flow from operations is up +43.74% year-on-year

    Cash from investing

    $8.56M
    UBX annual cash flow from investing activities is $8.56 million

    Cash from investing 1-year change

    -85.84%
    UBX annual cash flow from investing activities is down -85.84% year-on-year

    Cash from financing

    $77.00K
    UBX annual cash flow from financing activities is $77.00 thousand

    Cash from financing 1-year change

    +100.47%
    UBX annual cash flow from financing activities is up +100.47% year-on-year

    CAPEX

    CAPEX

    -
    UBX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    UBX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$20.86M
    UBX annual free cash flow is -$20.86 million

    Free cash flow 1-year change

    +43.76%
    UBX annual free cash flow is up +43.76% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    UBX annual gross profit margin value is unknown

    Operating margin

    -
    UBX annual operating profit margin value is unknown

    Net margin

    -
    UBX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -69.01%
    UBX annual return on assets is -69.01%

    ROE

    -400.22%
    UBX annual return on equity is -400.22%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    UBX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    UBX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -5.46
    UBX price to book ratio is -5.46

    PB ratio Sector rank

    6.22%
    UBX price to book ratio is higher than 6.22% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    UBX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    UBX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $11.80M
    UBX enterprise value is $11.80 million

    Enterprise value Sector rank

    23.1%
    UBX enterprise value is higher than 23.1% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.45
    UBX EV/EBITDA is -0.45

    EV/EBITDA Sector rank

    55.16%
    UBX EV/EBITDA is higher than 55.16% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.62
    UBX annual current ratio is 2.62

    Quick ratio

    -
    UBX annual quick ratio value is unknown

    Leverage

    Debt to equity

    3.62
    UBX annual debt to equity ratio is 3.62

    Interest coverage ratio

    -
    UBX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    UBX piotroski f-score value is unknown

    Altman Z-Score

    -
    UBX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 27, 25 HC Wainwright & Co.
    Neutral
    Apr 23, 25 HC Wainwright & Co.
    Buy
    Apr 23, 25 Chardan Capital
    Buy
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Chardan Capital
    Buy
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 Chardan Capital
    Buy
    Jan 10, 25 Chardan Capital
    Buy
    Aug 8, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with UBX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Unity Biotechnology, Inc.?
    • Does Unity Biotechnology, Inc. pay dividends?
    • What sector is Unity Biotechnology, Inc. in?
    • What industry is Unity Biotechnology, Inc. in?
    • What country is Unity Biotechnology, Inc. based in?
    • When did Unity Biotechnology, Inc. go public?
    • Is Unity Biotechnology, Inc. in the S&P 500?
    • Is Unity Biotechnology, Inc. in the NASDAQ 100?
    • Is Unity Biotechnology, Inc. in the Dow Jones?
    • When was Unity Biotechnology, Inc.'s last earnings report?
    • When does Unity Biotechnology, Inc. report earnings?

    What is the ticker symbol for Unity Biotechnology, Inc.?

    The ticker symbol for Unity Biotechnology, Inc. is NASDAQ:UBX

    Does Unity Biotechnology, Inc. pay dividends?

    No, Unity Biotechnology, Inc. does not pay dividends

    What sector is Unity Biotechnology, Inc. in?

    Unity Biotechnology, Inc. is in the Healthcare sector

    What industry is Unity Biotechnology, Inc. in?

    Unity Biotechnology, Inc. is in the Biotechnology industry

    What country is Unity Biotechnology, Inc. based in?

    Unity Biotechnology, Inc. is headquartered in United States

    When did Unity Biotechnology, Inc. go public?

    Unity Biotechnology, Inc.'s initial public offering (IPO) was on May 3, 2018

    Is Unity Biotechnology, Inc. in the S&P 500?

    No, Unity Biotechnology, Inc. is not included in the S&P 500 index

    Is Unity Biotechnology, Inc. in the NASDAQ 100?

    No, Unity Biotechnology, Inc. is not included in the NASDAQ 100 index

    Is Unity Biotechnology, Inc. in the Dow Jones?

    No, Unity Biotechnology, Inc. is not included in the Dow Jones index

    When was Unity Biotechnology, Inc.'s last earnings report?

    Unity Biotechnology, Inc.'s most recent earnings report was on August 6, 2025

    When does Unity Biotechnology, Inc. report earnings?

    The date for Unity Biotechnology, Inc.'s next earnings report has not been announced yet
    On this page